Related Experiment Video
Updated: Jul 12, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach
Carlos Escobar-Cervantes1, Antonio Pose Reino2, Pablo Díez-Villanueva3
1Cardiology Department, Hospital La Paz, Madrid, Spain.
Insights
Atrial fibrillation (AF) is a systemic vascular disease, not just a heart condition. Comprehensive management beyond stroke prevention is crucial for patients with AF.
Area of Science:
- Cardiology
- Vascular Medicine
- Systemic Diseases
Background:
- Atrial fibrillation (AF) is often viewed in isolation, but it presents significant systemic implications.
- Patients with AF face residual stroke risks and other comorbidities.
- AF is increasingly recognized as a complex vascular condition.
Purpose of the Study:
- To review the role of atrial fibrillation as a systemic vascular disease.
- To advocate for a holistic management approach in AF patients.
- To emphasize vascular protection beyond anticoagulation.
Main Methods:
- Literature review on atrial fibrillation as a systemic vascular disease.
- Analysis of AF's impact on various vascular beds and systemic pathways.
- Synthesis of expert opinion on comprehensive AF management.
Main Results:
- Atrial fibrillation is linked to stroke, cognitive impairment, atherosclerotic disease, and chronic kidney disease.
- AF involves hemodynamic and systemic changes like inflammation, oxidative stress, and endothelial dysfunction.
- A significant residual stroke risk persists despite anticoagulation.
Conclusions:
- Atrial fibrillation should be treated as a systemic vascular disease requiring a holistic approach.
- Management must extend beyond stroke prevention to include complete vascular protection.
- Comprehensive care addresses the multifaceted nature of AF and its associated risks.
Introduction:
Atrial fibrillation (AF) cannot be considered an isolated disease. Patients with AF should be managed using a comprehensive approach that is not limited to stroke prevention.
Areas Covered:
In this manuscript, the potential role of AF as a vascular disease that is managed as part of a holistic approach was reviewed.
Expert Opinion:
The residual risk of stroke in patients with AF reaches 1-2% annually, despite appropriate anticoagulation therapy. Additionally, patients with AF may develop cognitive impairment through stroke-independent pathways. Furthermore, patients with AF may have a higher risk of developing atherosclerotic vascular disease in various vascular beds and chronic kidney disease; conversely, patients with atherosclerotic disease may have an increased risk of developing AF. AF should be considered a truly systemic vascular disease, since it brings together several hemodynamic and systemic changes, including inflammation, oxidative stress, activation of the renin-angiotensin-aldosterone and sympathetic systems, as well as a prothrombotic state and endothelial dysfunction. In this regard, patients with AF should be treated based on a holistic approach that is not limited to oral anticoagulation but includes complete vascular protection.
Related Concept Videos
Atherosclerosis III: Management
Venous Thrombosis III: Interprofessional Care
Atherosclerosis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management

